Freedom Day Solutions, LLC Bristol Myers Squibb CO Transaction History

Freedom Day Solutions, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $51,350 - $57,016	-806 Reduced 16.18%	4,174 $266,000
Q1 2023 Apr 24, 2023	SELL	$65.71 - $74.53 $16,624 - $18,856	-253 Reduced 4.83%	4,980 $345,000
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $59,509 - $70,467	-869 Reduced 14.24%	5,233 $376,000
Q3 2022 Oct 28, 2022	SELL	$0.13 - $76.84 $210 - $124,480	-1,620 Reduced 20.98%	6,102 $434,000
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $19,680 - $21,674	271 Added 3.64%	7,722 $595,000
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $458,087 - $549,287	7,451 New	7,451 $544,000
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $211,087 - $246,078	-3,936 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $26,567 - $31,120	-449 Reduced 10.24%	3,936 $233,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $1.37 Million - $1.49 Million	-22,141 Reduced 83.47%	4,385 $293,000
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $27,652 - $31,100	-466 Reduced 1.73%	26,526 $1.68 Million
Q4 2020 Jan 28, 2021	SELL	$57.74 - $65.43 $47,981 - $54,372	-831 Reduced 2.99%	26,992 $1.67 Million
Q3 2020 Oct 26, 2020	SELL	$57.43 - $63.64 $72,189 - $79,995	-1,257 Reduced 4.32%	27,823 $1.68 Million
Q2 2020 Jul 27, 2020	SELL	$54.82 - $64.09 $11,950 - $13,971	-218 Reduced 0.74%	29,080 $1.71 Million
Q1 2020 Apr 10, 2020	BUY	$46.4 - $67.43 $37,259 - $54,146	803 Added 2.82%	29,298 $1.63 Million
Q4 2019 Jan 21, 2020	BUY	$49.21 - $64.19 $1.4 Million - $1.83 Million	28,495 New	28,495 $1.83 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Freedom Day Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Freedom Day Solutions, LLC with notifications on news.